194 related articles for article (PubMed ID: 12359059)
1. Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs.
Goto S; Kamada K; Soh Y; Ihara Y; Kondo T
Jpn J Cancer Res; 2002 Sep; 93(9):1047-56. PubMed ID: 12359059
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi.
Goto S; Ihara Y; Urata Y; Izumi S; Abe K; Koji T; Kondo T
FASEB J; 2001 Dec; 15(14):2702-14. PubMed ID: 11726546
[TBL] [Abstract][Full Text] [Related]
3. Nuclear glutathione S-transferase pi prevents apoptosis by reducing the oxidative stress-induced formation of exocyclic DNA products.
Kamada K; Goto S; Okunaga T; Ihara Y; Tsuji K; Kawai Y; Uchida K; Osawa T; Matsuo T; Nagata I; Kondo T
Free Radic Biol Med; 2004 Dec; 37(11):1875-84. PubMed ID: 15528046
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells.
Goto S; Iida T; Cho S; Oka M; Kohno S; Kondo T
Free Radic Res; 1999 Dec; 31(6):549-58. PubMed ID: 10630679
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
Zhang J; Ji J; Ji YB; Yuan F; Liu BY; Zhu ZG; Lin YZ
Ai Zheng; 2005 Apr; 24(4):432-7. PubMed ID: 15820065
[TBL] [Abstract][Full Text] [Related]
6. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
[TBL] [Abstract][Full Text] [Related]
7. Modification of chemo-radiosensitivity of a human lung cancer cell line by introduction of the glutathione S-transferase pi gene.
Miyara H; Hida T; Nishida K; Takahashi T; Sugiura T; Ariyoshi Y; Morishita M; Takahashi T; Ueda R
Jpn J Clin Oncol; 1996 Feb; 26(1):1-5. PubMed ID: 8551660
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin.
Rolland D; Raharijaona M; Barbarat A; Houlgatte R; Thieblemont C
Anticancer Res; 2010 Oct; 30(10):3951-7. PubMed ID: 21036708
[TBL] [Abstract][Full Text] [Related]
9. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.
Okuyama T; Maehara Y; Endo K; Baba H; Adachi Y; Kuwano M; Sugimachi K
Cancer; 1994 Aug; 74(4):1230-6. PubMed ID: 8055443
[TBL] [Abstract][Full Text] [Related]
10. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
[TBL] [Abstract][Full Text] [Related]
11. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
12. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Geng M; Wang L; Chen X; Cao R; Li P
Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers.
Soh Y; Goto S; Kitajima M; Moriyama S; Kotera K; Nakayama T; Nakajima H; Kondo T; Ishimaru T
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):264-70. PubMed ID: 15997922
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N
Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522
[TBL] [Abstract][Full Text] [Related]
15. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
[TBL] [Abstract][Full Text] [Related]
16. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.
Su F; Hu X; Jia W; Gong C; Song E; Hamar P
J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817
[TBL] [Abstract][Full Text] [Related]
17. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
Harbottle A; Daly AK; Atherton K; Campbell FC
Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
[TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
19. [Glutathione S transferases-pi].
Takahashi Y; Niitsu Y
Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate.
Tashiro K; Asakura T; Fujiwara C; Ohkawa K; Ishibashi Y
Anticancer Drugs; 2001 Sep; 12(8):707-12. PubMed ID: 11604559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
